Skip to content
Menu

RyISE

Primary Menu

  • Home
  • Original Neonatal Research Titles From India
    • Published in indexed journals
    • Unpublished neonatal research
      • Promising research ideas
      • Selected for LTS 2023
  • How to submit your research?
  • RyISE Board of Senior Reviewers
  • RyISE Reviewers
  • Submit your research
  • FAQ
  • Certificates
  • RyISE 2023 team​
  • RyISE Neo 2023 Awards
Search

Please note: All published posts are in random order.

LEVETIRACETAM AS FIRST LINE AGENT FOR SEIZURE REMISSION IN NEONATAL SEIZURES-A PROSPECTIVE ANALYTICAL STUDY

Posted onJune 16, 2023July 4, 2023Authoradmin

Kaju Dhanalakshmi Ahalya, N Chandrakumar

Kanchi Kama koti CHILDS Trust Hospital

CategoriesNeonatology, Unpublished neonatal researchTagscentral nervous system, levetiracetam, Neonatal Seizure

Post navigation

← Previous Previous post: RISK FACTORS OF MORTALITY AND MORBIDITY IN NEONATES WITH INTESTINAL OBSTRUCTION
Next → Next post: TO EVALUATE THE CLINICAL PROFILE AND OUTCOME OF INFANTS BORN WITH VERY LOW BIRTH WEIGHT

Categories

  • Neonatology
  • Published in indexed journals
  • Unpublished neonatal research
Copyright © 2025 RyISE. All Rights Reserved. | Clean Journal by Catch Themes
  • Home
  • Original Neonatal Research Titles From India
    • Published in indexed journals
    • Unpublished neonatal research
      • Promising research ideas
      • Selected for LTS 2023
  • How to submit your research?
  • RyISE Board of Senior Reviewers
  • RyISE Reviewers
  • Submit your research
  • FAQ
  • Certificates
  • RyISE 2023 team​
  • RyISE Neo 2023 Awards